GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Diamyd Medical AB (OSTO:DMYD B) » Definitions » Accounts Payable

Diamyd Medical AB (OSTO:DMYD B) Accounts Payable : kr12.99 Mil (As of May. 2025)


View and export this data going back to 2013. Start your Free Trial

What is Diamyd Medical AB Accounts Payable?

Diamyd Medical AB's Accounts Payable for the quarter that ended in May. 2025 was kr12.99 Mil.

Diamyd Medical AB's quarterly Accounts Payable increased from Nov. 2024 (kr7.02 Mil) to Feb. 2025 (kr11.00 Mil) and increased from Feb. 2025 (kr11.00 Mil) to May. 2025 (kr12.99 Mil).

Diamyd Medical AB's annual Accounts Payable declined from Aug. 2022 (kr9.78 Mil) to Aug. 2023 (kr4.89 Mil) but then increased from Aug. 2023 (kr4.89 Mil) to Aug. 2024 (kr16.61 Mil).

Diamyd Medical AB Accounts Payable Historical Data

The historical data trend for Diamyd Medical AB's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Diamyd Medical AB Accounts Payable Chart

Diamyd Medical AB Annual Data
Trend Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23 Aug24
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.25 5.57 9.78 4.89 16.61

Diamyd Medical AB Quarterly Data
Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.08 16.61 7.02 11.00 12.99

Diamyd Medical AB Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Diamyd Medical AB Accounts Payable Related Terms

Thank you for viewing the detailed overview of Diamyd Medical AB's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Diamyd Medical AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Diamyd Medical AB (OSTO:DMYD B) » Definitions » Accounts Payable
Comparable Companies
OSTO:SANION OSTO:XSPRAY OSTO:EGTX OSTO:HNSA OSTO:SYNACT OSTO:IBT B OSTO:GENO XSAT:HAMLET B OSTO:VICO OSTO:FLUO VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
DYMDF:USA
Address
Kungsgatan 29, Stockholm, SWE, SE-111 56
Website
https://www.diamyd.com
Diamyd Medical AB is a Sweden-based company engaged in the field of pharmaceutical development. It develops therapies using in-licensed substances glutamic acid decarboxylase (GAD) and GABA for the prevention or treatment of diabetes and other inflammatory diseases. The firm is focused on finding the cure for diabetes and other serious inflammatory diseases through pharmaceutical development and investments in stem cells and medical technology. Its product portfolio consists of Diamyd, for the treatment of autoimmune diabetes; Remygen, a regenerative and immunomodulatory therapy for the treatment of autoimmune diabetes and type 2 and type 1 diabetes.

Diamyd Medical AB Headlines

No Headlines